Table of Contents
The new report “Global Blood Monitoring & Cardiac Monitoring Devices Market Assessment & Forecast: 2015-2019” by Spearhead Acuity Business Research & Consulting group reveals that global market for blood monitoring & cardiac monitoring devices was valued at US$ 17,770.3 million in 2014 and expected to grow to US$ 24,830.1 million by 2019 at a CAGR of 6.8% from 2015 to 2019.
The report covers analysis for six regions of North America, Europe, Asia-Pacific, Latin America, Middle-East and Africa. The three major factors determining growth of the blood monitoring and cardiac monitoring systems are aging population, diabetes and obesity. Along with aging population, the rising incidence of diabetes and obesity has put tremendous pressure on the North American population. According to the American Diabetes Association, there are approximately 30 million people currently suffering from diabetes and approximately 1.5 million people had Type-1 diabetes in 2014. Diabetes single-handedly is the most damaging disease occurring across the world with 387 million people currently living with the disease as per IDF statistics. The Asia-Pacific region accounts for more than half of this population, which makes it a market with huge potential. Genetics has also played a major role in this according to several research studies in the past few years.
The blood monitoring devices market is comprised of four prominent product segments or categories, namely blood pressure monitors, blood glucose monitors, blood gas analyzers and blood cholesterol monitors. These devices monitor several parameters of blood such as the amount of blood sugar, oxygen concentration, pH and blood gas i.e. concentration of hydrogen ions (pH), partial pressure of carbon dioxide (pCO2) and partial pressure of oxygen (pO2), blood pressure and cholesterol. The report also provides analysis for cardiac monitoring devices market that encompasses five prominent products segments or categories, namely cardiac electrocardiogram (ECG) monitors, holter monitors, event monitors, output monitors and other monitors such as wrist rate monitors and strapped rate monitors. North America market captured around 36.4% market share of cardiac monitoring in 2014 and is a market leader in cardiac monitoring devices. This is attributed to the presence of major manufacturers in this region followed by the extensive research and development activities. Innovative less intensive blood monitoring machines have made testing less invasive; thus considering the high population pool of geriatric population, it is expected that the revenue from this market in North America will remain solid even in the near future. It is expected that the revenues for invasive blood and cardiac monitoring devices will decline as its market share is expected to be cannibalized by noninvasive or less invasive blood monitoring and cardiac monitoring devices.
SA-BRC analyzed the trends and dynamics of players across all segments of the blood monitoring and cardiac monitoring devices market. The movements of companies ranged from geographical expansion, innovation, partnerships and agreements and business development through sales and marketing. Since the global market is highly fragmented, most players in segments such as blood pressure monitors are depending on competitive pricing bringing down the fight to street level. Local players particularly in developing regions such as Latin America and Asia-Pacific dominate the market since the science behind the devices is quite old. Environmental and health regulations are now forcing companies to move towards developing devices devoid of mercury. Key players covered in this report are GE Healthcare, Philips Healthcare, Omron Healthcare, Roche, Mortara, Bayer Healthcare, Schiller AG, Dragerwerk AG, Abbott Laboratories, LifeScan (J&J), Medtronic Inc, SpaceLabs Healthcare, WelchAllyn, A&D Medical among several others.
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
Global Cardiac Holter Monitor Market: Overview This report on the Global Cardiac Holter Monitor market analyzes the current and future scenario of the global market. Rise in prevalence of cardiovascula ...
This report analyzes the worldwide markets for Electrodes for Medical Devices in US$ Thousand by the following Segments: Blood Gas Electrodes, Defibrillator Electrodes, ECG Electrodes, EEG/EMG/ENG Electrodes, ...
According to Stratistics MRC, the Global Continuous Cardiac Monitoring Devices market is expected to grow from $XX million in 2016 to reach $XX million by 2022 with a CAGR of XX%. Growing prevalence of ...